WallStreetZenWallStreetZen

NASDAQ: KPRX
Kiora Pharmaceuticals Inc Stock Ownership - Who owns Kiora Pharmaceuticals?

Insider buying vs selling

Have Kiora Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Brian M. StremPresident and CEO2023-03-0315,600$3.83
$59.75kBuy

1 of 1

KPRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KPRX insiders and whales buy or sell their stock.

KPRX Shareholders

What type of owners hold Kiora Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC103.19%7,478,202$4.26MInsider
Innoven Partenaires Sa Ipsa20.15%1,460,479$832.47kInsider
Ventech Capital Ii19.76%1,431,814$816.13kInsider
Private Equity Natixis9.30%674,205$384.30kInsider
Barbara Wirostko6.40%463,808$264.37kInsider
Sabby Management LLC4.31%312,369$178.05kInstitution
Walleye Capital LLC3.45%250,258$142.65kInstitution
Michael Garanzini2.71%196,250$111.86kInsider
Franz Obermayr1.40%101,613$57.92kInsider
Paul G. Chaney1.26%91,229$52.00kInsider

1 of 3

KPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KPRX5.13%94.87%Net Buying
SXTP0.00%30.17%
ZVSA0.92%13.43%Net Buying
CYCC16.33%59.68%
LIXT4.51%95.49%Net Buying

Kiora Pharmaceuticals Stock Ownership FAQ

Who owns Kiora Pharmaceuticals?

Kiora Pharmaceuticals (NASDAQ: KPRX) is owned by 9.14% institutional shareholders, 168.87% Kiora Pharmaceuticals insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Kiora Pharmaceuticals shareholder, owning 7.48M shares representing 103.19% of the company. Armistice Capital LLC's Kiora Pharmaceuticals shares are currently valued at $4.26M.

If you're new to stock investing, here's how to buy Kiora Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.